Showing results (1611-1620 of 2,038) with videos related to
Sort By:
Pageof 204
Molecular Systems Biology|March 28, 2026
Progress and new challenges in image-based profilingErik Serrano, John Peters, Jesko Wagner, et al.Cancer Discovery|April 29, 2017
Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP InhibitorsDavid Quigley, Joshi J Alumkal, Alexander W Wyatt, et al.Biorxiv : the Preprint Server for Biology|June 3, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient SurvivalXiaozhuo Liu, Eduardo Cortes, Yibing Ji, et al.Biorxiv : the Preprint Server for Biology|April 1, 2025
Stochastically Emergent Tumors offer in vivo whole genome interrogation of cancer evolution from non-malignant precursorsRuhollah Moussavi-Baygi, Matthew J Ryan, Woogwang Sim, et al.International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomyHimanshu R Lukka, Stephanie L Pugh, William U Shipley, et al.Cancer Research|December 8, 2016
RB Loss Promotes Prostate Cancer MetastasisChellappagounder Thangavel, Ettickan Boopathi, Yi Liu, et al.Cancer Discovery|September 21, 2012
Dual roles of PARP-1 promote cancer growth and progressionMatthew J Schiewer, Jonathan F Goodwin, Sumin Han, et al.Nature|July 21, 2022
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancerCameron Herberts, Matti Annala, Joonatan Sipola, et al.Antimicrobial Agents and Chemotherapy|June 27, 2026
Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metaboliteYili Xu, Albert Liclican, Xiaofeng Zhao, et al.International Journal of Radiation Oncology, Biology, Physics|January 2, 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate CancerHimanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, et al.Pageof 204